Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Regularly compare planned vs. actual spending, adjust assumptions, and use benchmarks to push your budget toward greater accuracy.
20,813 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
A bank ETF can be a reliable engine for a value-focused portfolio, capturing the cash-generating power of U.S. lender...
A notable stake from an experienced manager in a healthcare diagnostics stock signals a thoughtful, long term thesis....
A sweeping change is quietly redefining housing. This article explains the $48t “structural shift” housing and why it...
When a hedge fund disclosed a sizable new stake in Asbury Automotive, the market reacted. This guide breaks down why ...
Oil markets are tight and volatile as global inventories 11-year getting tighter. This guide explains what it means f...
Parents often wrestle with whether to buy new or used for a teen gift. This article analyzes how a used Bronco wrappe...
With SPY's yield hovering near 1% and valuations high, investors are turning to covered calls to generate cash flow. ...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
July has brought headlines that test investors' nerves. This piece breaks down what drove stock moves today, what Luc...
Novo Nordisk isn’t in the spotlight, but its steady cash flow and strong pipeline could unlock long-term gains. This ...
Berkshire Hathaway just repurchased stock, signaling a shift in how the company’s massive cash pile may be deployed. ...